Matthew S. Faber
Michigan State University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Matthew S. Faber.
PLOS ONE | 2013
Maria Tikhonenko; Todd A. Lydic; Madalina Opreanu; Sergio Li Calzi; Svetlana Bozack; Kelly M. McSorley; Andrew Sochacki; Matthew S. Faber; Sugata Hazra; Shane Duclos; Dennis L. Guberski; Gavin E. Reid; Maria B. Grant; Julia V. Busik
Objective The vasodegenerative phase of diabetic retinopathy is characterized by not only retinal vascular degeneration but also inadequate vascular repair due to compromised bone marrow derived endothelial progenitor cells (EPCs). We propose that n-3 polyunsaturated fatty acid (PUFA) deficiency in diabetes results in activation of the central enzyme of sphingolipid metabolism, acid sphingomyelinase (ASM) and that ASM represents a molecular metabolic link connecting the initial damage in the retina and the dysfunction of EPCs. Research Design and Methods Type 2 diabetic rats on control or docosahexaenoic acid (DHA)-rich diet were studied. The number of acellular capillaries in the retinas was assessed by trypsin digest. mRNA levels of interleukin (IL)-1β, IL-6, intracellular adhesion molecule (ICAM)-1 in the retinas from diabetic animals were compared to controls and ASM protein was assessed by western analysis. EPCs were isolated from blood and bone marrow and their numbers and ability to form colonies in vitro, ASM activity and lipid profiles were determined. Results DHA-rich diet prevented diabetes-induced increase in the number of retinal acellular capillaries and significantly enhanced the life span of type 2 diabetic animals. DHA-rich diet blocked upregulation of ASM and other inflammatory markers in diabetic retina and prevented the increase in ASM activity in EPCs, normalized the numbers of circulating EPCs and improved EPC colony formation. Conclusions In a type 2 diabetes animal model, DHA-rich diet fully prevented retinal vascular pathology through inhibition of ASM in both retina and EPCs, leading to a concomitant suppression of retinal inflammation and correction of EPC number and function.
Journal of Biological Chemistry | 2015
Caitlin A. Kowalsky; Matthew S. Faber; Aritro Nath; Hailey E. Dann; Vince W. Kelly; Li Liu; Purva Shanker; Ellen K. Wagner; Jennifer A. Maynard; Christina Chan; Timothy A. Whitehead
Background: A new method using comprehensive mutagenesis libraries, yeast display, and deep sequencing is proposed to determine fine conformational epitopes for three antibody-antigen interactions. Results: For three separate antigens, the experimentally determined conformational epitope is consistent with orthogonal experimental datasets. Conclusion: We conclude that this new methodology is reliable and sound. Significance: With this new method, four antibody-antigen interactions can be mapped per day. Knowledge of the fine location of neutralizing and non-neutralizing epitopes on human pathogens affords a better understanding of the structural basis of antibody efficacy, which will expedite rational design of vaccines, prophylactics, and therapeutics. However, full utilization of the wealth of information from single cell techniques and antibody repertoire sequencing awaits the development of a high throughput, inexpensive method to map the conformational epitopes for antibody-antigen interactions. Here we show such an approach that combines comprehensive mutagenesis, cell surface display, and DNA deep sequencing. We develop analytical equations to identify epitope positions and show the method effectiveness by mapping the fine epitope for different antibodies targeting TNF, pertussis toxin, and the cancer target TROP2. In all three cases, the experimentally determined conformational epitope was consistent with previous experimental datasets, confirming the reliability of the experimental pipeline. Once the comprehensive library is generated, fine conformational epitope maps can be prepared at a rate of four per day.
Current Opinion in Structural Biology | 2017
Emily E. Wrenbeck; Matthew S. Faber; Timothy A. Whitehead
The advent of next-generation sequencing (NGS) has revolutionized protein science, and the development of complementary methods enabling NGS-driven protein engineering have followed. In general, these experiments address the functional consequences of thousands of protein variants in a massively parallel manner using genotype-phenotype linked high-throughput functional screens followed by DNA counting via deep sequencing. We highlight the use of information rich datasets to engineer protein molecular recognition. Examples include the creation of multiple dual-affinity Fabs targeting structurally dissimilar epitopes and engineering of a broad germline-targeted anti-HIV-1 immunogen. Additionally, we highlight the generation of enzyme fitness landscapes for conducting fundamental studies of protein behavior and evolution. We conclude with discussion of technological advances.
PLOS ONE | 2014
Qi Wang; Maria Tikhonenko; Svetlana Bozack; Todd A. Lydic; Lily Yan; Nicholas Panchy; Kelly M. McSorley; Matthew S. Faber; Yuanqing Yan; Michael E. Boulton; Maria B. Grant; Julia V. Busik
Disruption of circadian regulation was recently shown to cause diabetes and metabolic disease. We have previously demonstrated that retinal lipid metabolism contributed to the development of diabetic retinopathy. The goal of this study was to determine the effect of diabetes on circadian regulation of clock genes and lipid metabolism genes in the retina and retinal endothelial cells (REC). Diabetes had a pronounced inhibitory effect on the negative clock arm with lower amplitude of the period (per) 1 in the retina; lower amplitude and a phase shift of per2 in the liver; and a loss of cryptochrome (cry) 2 rhythmic pattern in suprachiasmatic nucleus (SCN). The positive clock arm was increased by diabetes with higher amplitude of circadian locomotor output cycles kaput (CLOCK) and brain and muscle aryl-hydrocarbon receptor nuclear translocator-like 1 (bmal1) and phase shift in bmal1 rhythmic oscillations in the retina; and higher bmal1 amplitude in the SCN. Peroxisome proliferator-activated receptor (PPAR) α exhibited rhythmic oscillation in retina and liver; PPARγ had lower amplitude in diabetic liver; sterol regulatory element-binding protein (srebp) 1c had higher amplitude in the retina but lower in the liver in STZ- induced diabetic animals. Both of Elongase (Elovl) 2 and Elovl4 had a rhythmic oscillation pattern in the control retina. Diabetic retinas lost Elovl4 rhythmic oscillation and had lower amplitude of Elovl2 oscillations. In line with the in vivo data, circadian expression levels of CLOCK, bmal1 and srebp1c had higher amplitude in rat REC (rREC) isolated from diabetic rats compared with control rats, while PPARγ and Elovl2 had lower amplitude in diabetic rREC. In conclusion, diabetes causes dysregulation of circadian expression of clock genes and the genes controlling lipid metabolism in the retina with potential implications for the development of diabetic retinopathy.
International Journal of Molecular Sciences | 2012
James H. Resau; Nhan T. Ho; Karl Dykema; Matthew S. Faber; Julia V. Busik; Radoslav Z. Nickolov; Kyle A. Furge; Nigel Paneth; Scott Jewell; Sok Kean Khoo
Screening newborns for treatable serious conditions is mandated in all US states and many other countries. After screening, Guthrie cards with residual blood (whole spots or portions of spots) are typically stored at ambient temperature in many facilities. The potential of archived dried blood spots (DBS) for at-birth molecular studies in epidemiological and clinical research is substantial. However, it is also challenging as analytes from DBS may be degraded due to preparation and storage conditions. We previously reported an improved assay for obtaining global RNA gene expression from blood spots. Here, we evaluated sex-specific gene expression and its preservation in DBS using oligonucleotide microarray technology. We found X inactivation-specific transcript (XIST), lysine-specific demethylase 5D (KDM5D) (also known as selected cDNA on Y, homolog of mouse (SMCY)), uncharacterized LOC729444 (LOC729444), and testis-specific transcript, Y-linked 21 (TTTY21) to be differentially-expressed by sex of the newborn. Our finding that trait-specific RNA gene expression is preserved in unfrozen DBS, demonstrates the technical feasibility of performing molecular genetic profiling using such samples. With millions of DBS potentially available for research, we see new opportunities in using newborn molecular gene expression to better understand molecular pathogenesis of perinatal diseases.
Investigative Ophthalmology & Visual Science | 2011
Qi Wang; Svetlana Bozack; Todd A. Lydic; Kelly M. McSorley; Matthew S. Faber; Maria Tikhonenko; Julia V. Busik
Investigative Ophthalmology & Visual Science | 2013
Harshini Chakravarthy; Todd A. Lydic; Peter Jajou; Svetlana Bozack; Matthew S. Faber; Walter J. Esselman; Susanne Mohr; Julia V. Busik
Investigative Ophthalmology & Visual Science | 2012
Priyanka Pandey; Maria Tikhonenko; Svetlana Bozack; Matthew S. Faber; Todd A. Lydic; Julia V. Busik
Investigative Ophthalmology & Visual Science | 2012
Qi Wang; Svetlana Bozack; Matthew S. Faber; Walter J. Esselman; Julia V. Busik
Investigative Ophthalmology & Visual Science | 2012
Matthew S. Faber; Todd A. Lydic; Maria Tikhonenko; Svetlana Bozack; Sergey S. Seregin; Andrea Amalfitano; Vince A. Chiodo; Sanford L. Boye; William W. Hauswirth; Julia V. Busik